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Abstract 
Background: Volatile organic compounds (VOCs) can be intermediates of metabolic pathways and their levels in 
biological samples may provide a better understanding about diseases in addition to potential methods for diagnosis. 
Headspace analysis of VOCs in urine samples using solid phase micro extraction (SPME) coupled to gas chromatogra-
phy - mass spectrometry (GC-MS) is one of the most used techniques. However, it generally produces a limited profile 
of VOCs if applied to fresh urine. Sample preparation methods, such as addition of salt, base or acid, have been devel-
oped to improve the headspace-SPME-GC-MS analysis of VOCs in urine samples. These methods result in a richer 
profile of VOCs, however, they may also add potential contaminants to the urine samples, result in increased variability 
introduced by manually processing the samples and promote degradation of metabolites due to extreme pH levels. 
Here, we evaluated if freeze-drying can be considered an alternative sample preparation method for headspace-
SPME-GC-MS analysis of urine samples.
Results: We collected urine from three volunteers and compared the performances of freeze-drying, addition of 
acid (HCl), addition of base (NaOH), addition of salt (NaCl), fresh urine and frozen urine when identifying and quantify-
ing metabolites in 4 ml samples. Freeze-drying and addition of acid produced a significantly higher number of VOCs 
identified than any other method, with freeze-drying covering a slightly higher number of chemical classes, showing 
an improved repeatability and reducing siloxane impurities.
Conclusion: In this work we compared the performance of sample preparation methods for the SPME-GC-MS analy-
sis of urine samples. To the best of our knowledge, this is the first study evaluating the potential of freeze-dry as an 
alternative sample preparation method. Our results indicate that freeze-drying has potential to be used as an alterna-
tive method for the SPME-GC-MS analysis of urine samples. Additional studies using internal standard, synthetic urine 
and calibration curves will allow a more precise quantification of metabolites and additional comparisons between 
methods.
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Background
Volatile organic compounds (VOCs) represent a chemi-
cally diverse group of metabolites found in biological 
fluids, with a boiling point lower than 300 °C and gener-
ally containing less than 12 carbon atoms [1]. VOCs are 
intermediates of metabolic pathways and, thus, their con-
centrations are likely to change when the metabolism of 
a cell or an organism reaches a different metabolic state 
[2]. Therefore, the levels of VOCs in biological samples 
may provide a better understanding of mechanisms driv-
ing cellular processes, diagnose diseases and/or monitor 
their progression [3].
A diverse range of analytical methods, such as elec-
tronic noses [4], selected ion flow tube mass spectrom-
etry [5] and gas chromatography - mass spectrometry 
(GC-MS) [6], have been used to analyse VOCs in urine 
samples. Among them, GC-MS is perhaps one of the 
most popular [6]. Coupled to solid-phase micro extrac-
tion (SPME), it is possible to detect VOCs present in the 
headspace of urine samples [7]. The SPME fibre extracts 
metabolites, while the GC-MS performs both their sepa-
ration and detection.
The headspace-SPME-GC-MS analysis of fresh urine 
samples generally produces a limited profile of VOCs. 
Thus, several sample preparation methods have been 
proposed to enhance VOC profiling [6, 8]. The addition 
of salt (e.g NaCl), acid (e.g. HCl) or base (e.g. NaOH) 
solutions are the most common [9, 10]. In general, these 
sample preparation methods are expected to increase 
the concentration of compounds in the headspace of 
the urine samples by increasing the ionic strength of 
these samples, which result in a richer profile of VOCs 
detected by GC-MS [11].
Although the addition of salt, acid or base have been 
largely applied to the analysis of urine samples using 
headspace-SPME-GC-MS [12], they have some disadvan-
tages that may be critical according to the type of study 
being performed. First, there is not yet a well-established 
method or protocol for analysing VOCs in urine using 
headspace-SPME-GC-MS. Different laboratories use dif-
ferent urine sample volumes and particular volumes and 
concentrations of salt, acid or base solutions [13], which, 
ultimately, restricts the comparison of results across 
studies. Second, the salt, acid or base solutions added to 
the urine samples might contain impurities, which rep-
resent an extra source of variability potentially mislead-
ing the final biological interpretation. Third, extremes of 
pH coupled to the temperature used in the SPME extrac-
tion (e.g. 60 °C) may promote further reactions involving 
compounds in the urine [6]. These reactions potentially 
produce secondary volatile and non-volatile compounds. 
In this case, the VOC profiles reported by GC-MS will 
not represent the metabolite content of the urine sample 
at its sampling time. Finally, the GC-MS analysis of solu-
tions at extreme pH levels may promote the degradation 
of the GC column, which, consequently, shortens its life-
time and reduces the reproducibility across replicates 
(http://www.chromacademy.com/troubleshooter-gc/
resources/gc-phenomenex-troubleshooting-1). Extreme 
pH may lead to SPME fibre and septum degradation. 
Water can also promote degradation. Therefore, there is 
a need for an improved sample preparation method that 
produces a reliable VOC profile of urine samples ana-
lysed by headspace-SPME-GC-MS without degrading the 
column.
Freeze-drying is a dehydration process widely used 
in biochemistry studies [14], metabolomics studies [15] 
and in the industry for preserving perishable material 
[16]. In summary, the freeze-drying process is able to 
remove water from the material being processed while 
keeping it frozen. For metabolomics studies, it repre-
sents the ability of dehydrating samples without degrad-
ing metabolites. Here, we evaluate if freeze-drying 
can be considered an alternative sample preparation 
method for the analysis of urine samples using head-
space-SPME-GC-MS. For this, we compared a number 
of sample preparation methods. The number of VOCs 
identified, their chemical classes and the repeatability of 
their quantification were assessed when 4 ml urine sam-
ples from healthy volunteers were analysed fresh, fro-
zen at −80 °C, freeze-dried, with the addition of 1 ml of 
saturated NaCl solution (salt), with the addition of 1 ml 
of 5M HCl solution (acid) or with the addition of 1 ml 
of 5M NaOH solution (base). The results obtained here 
indicate that freeze-drying may be considered an alter-
native sample preparation method for SPME-GC-MS 
analysis of urine samples.
Results and discussion
Stability of headspace‑SPME‑GC‑MS
The stability of the headspace-SPME-GC-MS system 
used in this study was assessed with the use of a reference 
solution containing four compounds (Fig. 1). Most com-
pounds showed a variance in intensity of less than 1.3. 
Indole, however, showed a variance of 4.45. The expla-
nation for this variation is that indole is a compound 
detected at a high retention time (i.e. 39.57 min), which 
is a region of the chromatogram that generally shows 
a higher level of variation due to column bleed [17]. In 
addition, the stock solution of standards was kept at 
room temperature, which may have resulted in oxidation 
of indole. The urine samples were all randomly analysed 
by headspace-SPME-GC-MS. Therefore, any compound 
showing the same variation as indole along the time 
frame of this experiment would equally affect every sam-
ple preparation method tested.
Page 3 of 11Aggio et al. Chemistry Central Journal  (2016) 10:9 
Compound identification
In order to assess the performance of each treatment in 
recovering or extracting metabolites from urine samples, 
we compared the number of compounds identified across 
treatments and assessed the classes of compounds more 
likely to be extracted per treatment. Table 1 summarises 
the ratio of compounds identified per treatment in rela-
tion to compounds identified in fresh samples. Figure 2 
demonstrates that Freeze-dry and the addition of HCl 
produced a significantly higher number of VOCs identi-
fied than any other treatment (Freeze-dry vs Fresh, p < 
0.001; Freeze-dry vs HCl, p = 0.231; Freeze-dry vs NaCl, 
p < 0.001; Freeze-dry vs NaOH, p < 0.001; Freeze-dry vs 
Frozen, p < 0.001; HCl vs Fresh, p < 0.001; HCl vs NaCl, 
p < 0.001; HCl vs NaOH, p < 0.001; HCl vs Frozen, p < 
0.001; Mann–Whitney U test), while there is no signifi-
cant difference between Freeze-dry and HCl. For some 
samples, Freeze-dry and HCl reported six times more 
VOCs than Fresh, Frozen or NaCl, and 2–3 times more 
VOCs than NaOH. Figure 3 and Table 2 show a summary 
of the classes of compounds extracted by each treatment 
tested. Between compounds identified, Freeze-dry, HCl 
and NaOH recovered the most diverse classes of com-
pounds. Compared to HCl, Freeze-dry detected a lower 
average number of acids, aldehydes, aromatics, halogens, 
furans, sulfur containing compounds, and hydrocarbons 
per sample; while it detected a higher average number of 
ketones, amides, pyrroles and other nitrogen containing 
compounds per sample. Compared to NaOH, Freeze-
dry detected an equal or higher average number of com-
pounds belonging to most classes per sample, with the 
exception of aldehydes and pyrroles. The differences in 
the classes of compounds recovered between each treat-
ment tested (Table  2) are probably due to multiple fac-
tors. We know that the migration of compounds from 
the urine, or liquid phase, to the headspace of the vial, or 
gas phase, depends on the volume of the liquid phase, the 
volume of the gas phase and the affinity of compounds 
for the liquid and gas phases [18]. For example, the addi-
tion of salt is known to modify the matrix of the sample 
by increasing ionic activity. It decreases the solubility of 
compounds in the liquid phase, which results in more 
compounds moving to the gas phase. It is known that 
the addition of acid reduces the pH of the solution and 
increases the volatility of acids, while the addition of base 
increases the pH of the solution and increases the vola-
tility of bases [18]. To the best of our knowledge, there 
is no work in the literature suggesting or discussing 
about headspace-SPME-GC-MS analysis of freeze-dried 
urine. Based on the results we found, we hypothesize 
that Freeze-dry improves the recovery of VOCs in urine 
samples by changing the volumes of the liquid and the 
gas phases. Freeze-drying considerably reduces the vol-
ume of the liquid phase while it increases the volume of 
the gas phase, which seems to promote the migration of 
compounds to the headspace of the vial. This mirrors the 
fact that small difference were observed in VOCs recov-
ered by freeze-drying and other drying methods, such 
as air drying, high temperature drying (80 °C to 120 °C) 
and vacuum drying, when treating samples of ginger [19] 
and Wuyi Rock tea [20]. Furthermore, some of the com-
pounds detected when using HCl or NaOH may result 
from compound degradation potentially promoted by the 
extreme pH levels of these solutions coupled to the high 
temperatures involved in the SPME-GC-MS analysis. 
Fig. 1 Intensity of compounds present in the reference solution 
throughout the experiment. A stock of reference solution was 
prepared at the beginning of the experiment. A 2 ml sample of the 
reference solution was analysed on the same days that urine samples 
were processed. The intensities of reference compounds were nor-
malized by their intensities detected on day 1
Table 1 Ratio of  compounds identified per  treatment 
tested in relation to fresh samples
The number of compounds identified by each treatment were normalized by the 
average number of compounds identified in urine samples analysed fresh (SE 
= standard error). Mann–Whitney U test compared the number of metabolites 
reported by each treatment in relation to Freeze-dry
Treatment Mean Median S.E. Mann–Whitney
Freeze-dry 5.18 6.03 0.45 –
Fresh 1.00 1.03 0.02 <0.001
HCl 5.96 6.15 0.35 0.231
NaCl 0.99 1.02 0.02 <0.001
NaOH 2.97 2.82 0.09 <0.001
Frozen 0.99 1.06 0.05 <0.001
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In addition, although Freeze-dry was able to recover 
a higher number of compounds from a wider range of 
chemical classes, VOCs may be lost during the freeze-
drying process. Additional experiments will allow us to 
further understand the chemistry and physics behind the 
headspace-SPME-GC-MS analysis of freeze-dried urine 
samples.
Compound quantification
In metabolomics, a coefficient of variation (CV) of 30 % 
is generally accepted as a variation threshold [21]. It is 
not recommended to draw biological interpretations 
based on compounds showing a CV higher than 30 %. 
Figure  4 shows the distribution of the CVs calculated 
for the compounds identified by each treatment tested 
in this study. Freeze-dry and Fresh were the most repro-
ducible treatments (Fig.  4), with 85.11 and 85.94 % of 
metabolites associated with CVs lower than 30 %, respec-
tively. Surprisingly, Frozen (71.43 %) showed significantly 
less repeatability when compared to Fresh (85.94 %) (p = 
0.043; prop.test). It may be a result of the extra steps per-
formed on Frozen samples (e.g. freezing and defrosting). 
NaCl, NaOH and HCl showed 61.9 %, 75.6 % and 78.7 % 
of compounds with CV lower than 30 %, respectively. 
Fig. 2 Number of compounds identified per treatment for each volunteer. For the overall results, Mann–Whitney U test was applied to compare 
the number of compounds identified by Freeze-dry in relation to all the other treatments tested. (*) p value < 0.05; (**) p value < 0.01; (***) p value 
< 0.001; n ≥ 3
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The statistical comparisons of compounds with CV lower 
than 30 % across treatments is presented in Table  3. A 
single or multiple internal standards are generally applied 
for reducing the variability that may be introduced in the 
system during sample preparation. The best compound, 
or compounds, to be used as internal standard may vary 
according to the method used, the type of sample being 
analysed and the classes of metabolites being targeted. To 
the best of our knowledge, this is the first metabolomics 
study testing Freeze-dry as a sample preparation method 
for the headspace-SPME-GC-MS analysis of urine sam-
ples. In this study we generated the first SPME-GC-MS 
Fig. 3 Chemical classes of compounds per treatment
Table 2 Average number of compounds identified per sample per class of compound and treatment tested (n ≥ 12)
A Fresh; B Frozen; C NaCl; D NaOH; E HCl; F Freeze-dry
* N-Containing Nitrogen containing compounds
** O-Containing Oxygen containing compounds
*** S-Containing Sulfur containing compounds
Class Fresh Frozen NaCl NaOH HCl Freeze‑dry Mann–Whitney | p values
A vs. F B vs. F C vs. F D vs. F E vs. F
Alcohol 1 1 1 1.2 7.7 7.5 0.001 0.001 0.001 <0.001 0.889
Acid 0 0 0 1 5.3 3.1 NA NA NA 0.112 0.001
Aldehyde 1.9 1.9 2.2 4 7.8 1.1 0.002 0.009 0.003 <0.001 <0.001
Aromatic 5.9 5.6 5.5 10.3 30.2 21.3 <0.001 <0.001 <0.001 <0.001 <0.001
Halogen 0 0 0 0 1 0 NA NA NA NA NA
Ketone 8.1 8.1 7.9 22.6 20.6 36.9  <0.001  <0.001  <0.001  <0.001  <0.001
Furan 1.7 1.6 1.3 1.1 9.8 8.7  <0.001  <0.001 0.001  <0.001 0.048
N-Containing* 2.1 2.1 2.1 8.3 2 11.2  <0.001  <0.001  <0.001 0.003  <0.001
O-Containing** 12.2 12.5 12.5 29.6 62.9 63.2  <0.001  <0.001  <0.001  <0.001 0.849
S-Containing*** 1 1 1 3.6 7.7 3.2 0.124 0.029 0.124 0.203  <0.001
Hydrocarbon 3.9 3.7 4.2 6.5 37.2 14  <0.001 <0.001  <0.001  <0.001  <0.001
Ester 0 1 1 1 2.3 2.9 NA 0.007 0.024  <0.001 0.198
Amide 0 0 0 0 0 1 NA NA NA NA NA
Pyrrole 1 1 1 2.5 0 1.8  <0.001  <0.001  <0.001 0.011 NA
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profile of metabolites found in freeze-dried human urine. 
Thus, no internal standard could be applied in this study. 
We are currently designing additional experiments to 
identify the best metabolites to be used as internal stand-
ard when freeze-drying urine samples. 
Sample effects on chromatography
The type of samples or treatment applied to a sample 
prior to headspace-SPME-GC-MS analysis may result in 
a higher or lower degradation of the SPME fibre, septum, 
or GC column (http://www.chromacademy.com/trouble-
shooter-gc/resources/gc-phenomenex-troubleshooting-1). 
Figure 5 shows the abundance of compounds originating 
from apparent polysiloxane degradation according to the 
treatment applied. Polydimethylsiloxane, for instance, 
is used in septa, SPME fibre and stationary phase used 
here. Table  4 shows their identifications and the results 
of statistical comparisons. Compared to HCl and NaOH, 
Freeze-dry resulted in detection of significantly lower or 
equal level of all column degradation products, with the 
exception of Phenyl-pentamethyl-disiloxane (RT_25.28). 
Compared to Fresh and NaCl, Freeze-dry showed higher 
abundances of two compounds, lower abundance of one 
compound and the same abundances of four compounds 
(Fig.  5). These results indicate that Freeze-dry does not 
promote further column degradation than any other 
method tested.
Practicalities in sample processing
Once HCl and NaOH solutions are prepared and ready to 
use, they can be quickly added to urine samples prior to 
headspace-SPME-GC-MS analysis. However, it requires 
someone manually adding these solutions to urine sam-
ples and extra care has to be taken to avoid contamination 
of these chemical solutions throughout the experiment, 
which would introduce variability to the system and 
potentially mislead the biological interpretation. The 
SPME-GC-MS analysis of the pure compounds (i.e. salt, 
base or acid) can certainly be performed to potentially 
identify contaminants, however, it results in additional 
time and cost associated to the study being performed. 
On the other hand, Freeze-dry is safe and only requires 
a freeze-drier machine. No specialized skills, other than 
operating a freeze-drier machine, are necessary and there 
is a very low risk of sample contamination. In this study, 
Fig. 4 Coefficient of variation of metabolites identified when testing the different sample preparation methods. The coefficient of variations were 
calculated per volunteer before plotting. Each dot represents a single metabolite
Table 3 Comparison of  compounds showing coefficient 
of variation lower than 30 % and Freeze-dry
Prop.test Prop.test
Comparison p value Comparison p value
Freeze vs Fresh 0.768 HCl vs NaOH 0.489
Freeze vs Frozen 0.016 NaOH vs Fresh 0.068
Freeze vs NaCl <0.001 NaOH vs Frozen 0.632
Freeze vs NaOH 0.014 NaOH vs NaCl 0.056
Freeze vs HCl 0.052 NaCl vs Fresh 0.002
HCl vs Fresh 0.148 NaCl vs Frozen 0.345
HCl vs Frozen 0.272 Frozen vs Fresh 0.043
HCl vs NaCl 0.007
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Fig. 5 Gas chromatography column degradation. This figure shows the relative abundances of identified siloxanes per treatment tested. Com-
pound IDs are based on their retention times
Table 4 Statistics of column degradation (n ≥ 12). IDs are based on the retention time of each metabolite
A Freeze-dry; B Fresh; C HCl; D NaCl; E NaOH; F Frozen
- Identified in a single treatment
NA not identified in any of the tested treatments
* Isopropoxy-1,1,1,7,7,7-hexamethyl-3,5,5-tris(trimethylsiloxy)tetrasiloxane
IDs Name CAS ANOVA tTest | p values
A–B A–C A–D A–E A–F
RT_18.02 Cyclotrisiloxane, hexamethyl- 541-05-9 0.000 0.000 0.000 0.000 0.000 0.000
RT_24.35 Cyclotetrasiloxane, octamethyl- 556-67-2 0.000 0.091 0.000 0.010 0.000 0.001
RT_25.28 Phenyl-pentamethyl-disiloxane 14920-92-4 0.001 – 0.000 0.240 – 0.775
RT_28.78 Diisopropyl(ethoxy)silane 90633-16-2 – NA NA NA – NA
RT_29.80 Cyclopentasiloxane, decamethyl- 541-02-6 0.000 0.000 0.591 0.000 0.370 0.095
RT_35.20 Cyclohexasiloxane, dodecamethyl- 540-97-6 0.000 0.000 0.031 0.000 0.032 0.188
RT_40.19 Isopropoxy* 71579-69-6 0.000 0.246 0.005 0.449 0.013 0.115
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we freeze-dried samples for 18 h in order to assure that 
samples would be completely dry. However, this freeze-
drying time can certainly be reduced depending on the 
freeze-drying machine available. In addition, Freeze-dry 
is considerably less labour intensive than NaOH, HCl 
or NaCl, and researchers are free to perform any other 
task while samples are freeze-drying. Furthermore, the 
experiment presented here was performed using the 
same GC-MS configuration for every treatment tested, 
which included a delay of 4  min prior to MS detection. 
This delay is generally applied to avoid the water peak. 
Freeze-dried samples contain no water, therefore, this 
delay may be removed, which potentially results in addi-
tional compounds being detected. Further experiments 
will allow to confirm or reject this hypothesis. Addition-
ally, although tested in urine, the method suggested here 
could be applied to other complex aqueous samples such 
as waste water and food samples.
Experimental
Stock solutions
Sodium chloride (NaCL, ≥99.5 %) and hydrochloric acid 
(HCl, >37  %) were obtained from Sigma Aldrich, Dor-
set, UK. Sodium hydroxide (NaOH, >97 %) was obtained 
from BDH limited, Poole, UK. A 100  ml stock solution 
of saturated sodium chloride (salt solution) was prepared 
with distilled water and 38  g of NaCl; a 100  ml stock 
solution of 5M sodium hydroxide (base solution) was 
prepared with distilled water and 20  g of NaOH; and a 
100 ml stock solution of 5M hydrochloric acid (acid solu-
tion) was prepared by diluting concentrated hydrochloric 
acid with distilled water.
Volunteer recruitment
The study presented here was performed in accordance 
with the Declaration of Helsinki and ethical approval was 
obtained from the North Wales Research Ethics Com-
mittee—West (REC reference number 13/WA/0266) 
with the Royal Liverpool and Broadgreen University 
Hospitals as research sponsor. Three healthy volunteers 
were recruited after obtaining informed consent. Volun-
teers were healthy male subjects of age 29 ± 2.5 years old 
(mean ±  standard deviation) who were taking no medi-
cation for at least 4 months prior to sample collection.
Urine samples
A 200  ml sample of first pass urine was collected from 
each volunteer and quickly divided into 30 aliquots of 
4  ml stored in 10  ml vials for SPME-GC-MS analysis 
(Sigma-Aldrich, Dorset, UK). From these, twenty-five ali-
quots were stored at −80 °C while five aliquots were kept 
at room temperature to be analysed within 15 h of sam-
ple collection.
Freeze‑drying
An Edwards EF4 Modulyo freeze-dryer (Edwards High 
Vacuum, UK) operated at −35  °C and eight mbar was 
used to freeze-dry for 18  h five aliquots of 4  ml urine 
samples from each volunteer previously frozen at −80 °C.
Headspace‑SPME‑GC‑MS analysis
A Perkin Elmer Clarus 500 GC/MS quadruple bench top 
system (Beaconsfield, UK) was used in combination with 
a Combi PAL auto-sampler (CTC Analytics, Switzerland) 
for the analysis of all samples. The GC column used was 
a Zebron ZB-624 with inner diameter 0.25  mm, length 
60 m, film thickness 1.4 µm (Phenomenex, Maccles field, 
UK). The carrier gas used was helium of 99.996 % purity 
(BOC, Sheffield, UK). A CAR-PDMS 85 µm fibre was 
used to extract VOCs from the headspace air above the 
samples for 20 minutes (Sigma-Aldrich, Dorset, UK). The 
fibre was pre-conditioned before use, in accordance with 
the manufacturer manual. Urine samples were placed in 
an incubation chamber at 60  °C for 30 min before fibre 
adsorption. The fibre desorption conditions were 5  min 
at 220 °C. The initial temperature of the GC oven was set 
at 40 °C and held for 2 min before increasing to 220 °C at 
a rate of 5 °C/min and held for 4 min with a total run time 
of 42 min. A solvent delay was set for the first 4 min and 
the MS was operated in electron impact ionization EI+ 
mode, scanning from ion mass fragments 10–300  m/z 
with an inter scan delay of 0.1 s and a resolution of 1000 
at FWHM (Full Width at Half Maximum). The helium 
gas flow rate was set at 1  ml/min. Urine samples were 
randomly analysed by headspace-SPME-GC-MS within 
14 h following their treatment.
Experimental conditions
The following treatments or sample preparation methods 
were applied to the urine samples collected from each 
volunteer prior to analysis by headspace-SPME-GC-MS: 
Fresh, where five aliquots were kept at room temperature 
and quickly analysed after collection; Frozen, where five 
aliquots were frozen at −80 °C and defrosted; Freeze-dry, 
where five aliquots were frozen at −80 °C and freeze-
dried for 18 h; NaCl, where five aliquots were frozen at 
−80 °C, defrosted and treated with 1 ml of salt solution 
(i.e. saturated NaCl); HCl, where five aliquots were fro-
zen at −80  °C, defrosted and treated with 1  ml of acid 
solution (i.e. HCl 5M); and NaOH, where five aliquots 
were frozen at −80  °C, defrosted and treated with 1  ml 
of base solution (i.e. NaOH 5M). In total, 15 samples of 
each treatment, five samples from each volunteer, were 
analysed by headspace-SMPE-GC-MS. The dry resi-
due of each freeze-dried urine was directly analysed by 
headspace-SMPE-GC-MS with no addition of water or 
any other substance. We compared the number of VOCs 
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identified, the classes of compounds identified and the 
variability in metabolite quantification when using each 
treatment. In addition, we compared the GC column 
degradation promoted by each treatment.
Reference solution
Although the urine samples were randomly analysed, we 
assessed the stability of the headspace-SPME-GC-MS 
analysis method throughout the study by preparing a 
stock reference solution containing four compounds dis-
solved in water: 2-pentanone (CAS 107-87-9), pyridine 
(CAS 110-86-1), benzaldehyde (CAS 100-52-7) and indole 
(CAS 120-72-9). A 2 ml aliquot of this reference solution 
was then analysed on the days the urine samples were 
analysed. These compounds were selected as reference 
compounds as their retention times were considerably 
spread across the GC-MS run. A single stock of reference 
solution was prepared and used throughout the experi-
ment. The stock solution was stored at room temperature.
Laboratory air
In order to correct the results for potential air contami-
nants, samples of the laboratory air were analysed among 
urine samples. A total of 22 laboratory air samples were ana-
lysed throughout the study. Compounds found in more than 
50 % of the air samples (Additional file 1) were considered 
contaminants and were removed from the data analysis.
Mass spectral library
Two mass spectral libraries were built for this study 
(Additional files 2 and 3), one for processing samples 
from the reference solution and another for processing 
urine samples. They were both built using the Automated 
Mass Spectral Deconvolution System (AMDIS-version 
2.71, 2012) in conjunction with the NIST mass spectral 
library (version 2.0, 2011). The AMDIS configuration 
used is available through Additional file 4.
Data analysis
The GC-MS data were processed using AMDIS in con-
junction with the R package Metab [22]. All statistics 
were performed using R software [23]. A total of 90 urine 
samples were analysed by headspace-SPME-GC-MS, 30 
samples per volunteer (Additional file 5). Outlier samples 
were those found to contain considerably fewer metabo-
lites in comparison to the rest of the technical replicates. 
Principal component analysis was used to support the 
identification of outliers. These were removed from the 
analysis and comprised of seven samples from volun-
teer one (one frozen sample, two samples with NaCl, two 
samples with HCl and two freeze-dried samples) and two 
samples from volunteer three (one fresh sample and one 
sample with HCl). Every treatment tested is represented 
by a minimum of three urine samples. The p values lower 
than 0.05 were considered as significant.
Metabolite identification
Initially, the number of compounds identified per sample 
was determined for each volunteer. For an overall com-
parison across treatments, the number of compounds 
identified for a volunteer for all the different treatments 
tested was divided by the average number of compounds 
identified for this specific volunteer when using fresh 
urine. Compounds present in less than 30 % of the sam-
ples within a particular condition tested were considered 
false positives and, thus, were removed from the analysis. 
In this case, the levels detected for this specific compound 
were replaced by NA within samples of this particular 
condition. A Shapiro test indicated that the number of 
compounds identified per condition was not normally dis-
tributed. Thus, the Mann–Whitney U test was applied for 
comparing the number of compounds identified across 
treatments. The identified compounds were divided in 
chemical classes according to their functional groups. A 
single compound may have multiple functional groups, 
thus, it may be part of multiple chemical classes.
Metabolite quantification
The coefficient of variation (CV) (i.e. standard deviation 
of abundance divided by the mean abundance and multi-
plied by 100) was calculated per volunteer and per treat-
ment for each compound identified. The CVs associated 
with each volunteer were then combined per treatment 
and the proportion of compounds showing CVs lower 
than 30 % was calculated. In addition, the proportion of 
compounds showing a CV of less than 30 % across treat-
ments was compared statistically using 2-sample test 
for equality of proportions with continuity correction 
through the R function prop.test.
Polysiloxane or column degradation
Polysiloxanes, as part of the silicone septa, part of the 
SPME fibre or stationary phase of the GC column can 
degrade, resulting in its de-polymerisation and produc-
tion of volatile siloxanes. In order to identify if the differ-
ent sample treatments tested may promote degradation, 
we compared the abundances of compounds originating 
from column degradation across treatments. Siloxanes 
containing the ion fragment 73 were defined as com-
pounds originating from decomposition [24]. Student 
t test and one-way analysis of variance (ANOVA) were 
applied on the log transformed abundances of com-
pounds in order to assess statistical differences between 
treatments. For this analysis, samples that received the 
same treatment were considered as belonging to the 
same data class or experimental condition, disregarding 
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the volunteer id. Compounds present in less than 30 % of 
the samples of all the treatments tested were considered 
as false positives and, thus, were removed from the analy-
sis (Additional file 6).
Conclusion
For most metabolomics studies, the ideal sample prepa-
ration method would be easy to perform, quick, cheap, 
accurate, able to recover a high number of compounds of 
multiple classes and be highly reproducible. The results 
presented here indicate that HCl and Freeze-dry were 
the methods that reported the most enhanced profiles of 
VOCs, with Freeze-dry covering a slightly higher number 
of compound classes, showing better repeatability across 
replicates and producing a significantly lower level of most 
polysiloxane degradation products. In addition, Freeze-dry 
is considerably easier to perform, safer and can be cheaper 
than alkaline or acidic treatments if a freeze-drier is avail-
able, which is generally the case for most universities with 
laboratories of chemistry and/or biology. The use of multi-
ple sample preparation methods is certainly recommended 
for untargeted metabolomics when financial resources 
are available and the study design allows it. The results 
reported here indicate that freeze-drying urine samples 
for SPME-GC-MS analysis is a potential alternative sam-
ple preparation method. A larger experiment using inter-
nal standard will allow to confirm the results reported 
here and further understand chemistry and physics behind 
free-drying urine samples for SPME-GC-MS analysis.
Additional files
Additional file 1. Air contaminants. This csv file contains the metabolites 
found as air contaminants. These metabolites were detected in laboratory 
air samples analysed by SPME-GC-MS. This file can be visualised using a 
text editor.
Additional file 2. Mass spectral library for processing reference solution. 
This msl file is the AMDIS library containing the compounds present in 
the reference solution used in this study. This file can be visualised using 
a text editor or it can be loaded into AMDIS software. Please see the user 
manual provided with AMDIS to obtain all the necessary information to 
load a new library.
Additional file 3. Mass spectral library for processing urine samples. This 
msl file is the AMDIS library built to identify compounds in the urine sam-
ples analysed in this study. This library was built using NIST mass spectral 
library version 2.0, 2011. This file can be visualised using a text editor or it 
can be loaded into AMDIS software. Please see the user manual provided 
with AMDIS to obtain all the necessary information to load a new library.
Additional file 4. AMDIS configuration. This ini file contains the settings 
of the AMDIS software used in this study. Please see the user manual 
provided with AMDIS to obtain all the necessary information to use this 
configuration file when analysing GC-MS samples with AMDIS.
Additional file 5. Metabolite found in urine samples. This csv file con-
tains the metabolites found in the samples analysed in this study. This file 
can be visualised using a text editor.
Additional file 6. Column degradation. This csv file contains the 
metabolites defined as product of GC column degradation. This file can 
be visualised using a text editor.
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